A common uptake system for serotonin and dopamine in human platelets.
Kinetic and pharmacologic properties of uptake of serotonin and dopamine by normal human platelets have been investigated to test whether platelets can be employed as a model system for the reuptake of serotonin and dopamine in brain. Uptake of serotonin into platelets closely resembles reuptake of serotonin into serotonergic neurons. In contrast, uptake of dopamine into platelets appears to be mediated inefficiently via the specific serotonin uptake mechanism, based upon several lines of evidence. Serotonin and dopamine compete with each other, Antidepressant drugs, which are competitive inhibitors of uptake of both of these neurotransmitters, act at the same concentration of drug despite large differences in the Km values. Serotonin antagonists inhibit both serotonin and dopamine uptake. Finally, a serotonin-specific uptake inhibitor (fluoxetine) blocks dopamine, as well as serotonin, uptake.
D000929:Antidepressive Agents, Tricyclic / Q000494:pharmacology; D001693:Biological Transport, Active / Q000187:drug effects; D001792:Blood Platelets / Q000187:drug effects / Q000378:metabolism*; D003913:Dextroamphetamine / Q000494:pharmacology; D004298:Dopamine / Q000097:blood*; D018492:Dopamine Antagonists; D006801:Humans; D066298:In Vitro Techniques; D007700:Kinetics; D012701:Serotonin / Q000097:blood*; D012702:Serotonin Antagonists / Q000494:pharmacology
D000929:Antidepressive Agents, Tricyclic; D018492:Dopamine Antagonists; D012702:Serotonin Antagonists; D012701:Serotonin; D003913:Dextroamphetamine; D004298:Dopamine